Principal Investigator

Awardee Organization

University Of Tx Md Anderson Can Ctr
United States

Fiscal Year
Activity Code
Early Stage Investigator Grants (ESI)
Not Applicable
Project End Date

Efficacy and Safety of Rapid-Onset Opioids for Exertional Dyspnea in Cancer Patients

Dyspnea is one of the most common and distressing symptoms associated with cancer, occurring in up to 70% of patients. The vast majority of patients with dyspnea experience frequent episodes of breathlessness triggered by daily activities, such as walking and bathing. Understandably, dyspnea with exertion can significantly limit patients' daily function and negatively impact their quality of life. If uncontrolled, these highly distressing dyspnea episodes can result in costly emergency room visits and hospitalizations. Because exertional dyspnea is underresearched, few effective treatment options are available. The long-term goal of our group's research is to develop effective, evidence-based therapies for dyspnea in patients with cancer. Exertional dyspnea is particularly difficult to treat because of its rapid onset, short duration, and high intensity. This raises the possibility that rapid-onset opioids that are currently approved for breakthrough cancer pain may be effective as prophylactic treatment to reduce exertional dyspnea and maximize function. On the basis of our preliminary data from recent clinical trials, we hypothesize that fentanyl sublingual spray (FSS) is effective in relieving exertional dyspnea. The overall objective of the proposed 3-arm, double-dummy, parallelgroup randomized clinical trial is to compare the efficacy of FSS, morphine sulfate, and placebo in exertional dyspnea. The primary specific aim of this study is to compare the effect of prophylactic FSS, morphine sulfate, and placebo on the intensity of exertional dyspnea at the end of a shuttle walk test (SWT). In the second specific aim, we will compare their effects on SWT distance, average daily dyspnea, personalized daily activity, symptom burden, and quality of life. The third aim is to explore their effects on neurocognitive function, addictive potential, adverse effects, and pattern of opioid use. After obtaining written informed consent, we will monitor patients closely on usual opioids for 5 days before randomly assigning them to receive FSS, morphine sulfate, or placebo prophylactically once daily for 14 days. The proposed study is innovative in that the indications (i.e., exertional dyspnea and prophylactic management), intervention (i.e. FSS, proportionally dosed), patient population (i.e., patients with cancer), patient-reported outcome measures (e.g. personalized dyspnea activity, Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events instrument, and Drug effects Questionnaire), and study design (i.e. home setting) that it will address are novel. The expected outcome of the proposed study is that FSS will be established as a treatment option for exertional dyspnea in patients with cancer while a rich dataset will be provided on the neurocognitive effects and addictive potential of opioids to inform safe opioid use during this era of opioid crisis. Successful completion of this adequately powered trial will have a positive effect on patient care by alleviating the intensity of exertional dyspnea, enhancing patients' ability to function in their daily lives, and improving the quality of life of these highly distressed patients.


  • Tang M, Chen M, Bruera E, Hui D. Association among rescue neuroleptic use, agitation, and perceived comfort: secondary analysis of a randomized clinical trial on agitated delirium. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2021 Dec;29(12):7887-7894. Epub 2021 Jun 29. PMID: 34184130
  • Mo L, Urbauer DL, Bruera E, Hui D. Recommendations for supportive care and best supportive care in NCCN clinical practice guidelines for treatment of cancer: Differences between solid tumor and hematologic malignancy guidelines. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2021 Dec;29(12):7385-7392. Epub 2021 May 29. PMID: 34052931
  • Hui D, De La Rosa A, Chen J, Delgado Guay M, Heung Y, Dibaj S, Liu D, Bruera E. Palliative care education and research at US cancer centers: A national survey. Cancer. 2021 Jun 15;127(12):2139-2147. Epub 2021 Mar 4. PMID: 33662148
  • Hui D, Hoge G, Bruera E. Models of supportive care in oncology. Current opinion in oncology. 2021 Jul 1;33(4):259-266. PMID: 33720070
  • Hui D, Hernandez F, Larsson L, Liu D, Kilgore K, Naberhuis J, Virgilio A, Reddy S, Reddy A, Dalal S, Haider A, Driver L, Azhar A, Dev R, Bruera E. Prophylactic Fentanyl Sublingual Spray for Episodic Exertional Dyspnea in Cancer Patients: A Pilot Double-Blind Randomized Controlled Trial. Journal of pain and symptom management. 2019 Oct;58(4):605-613. Epub 2019 Jul 2. PMID: 31276809
  • Chang YK, Kaplan H, Geng Y, Mo L, Philip J, Collins A, Allen LA, McClung JA, Denvir MA, Hui D. Referral Criteria to Palliative Care for Patients With Heart Failure: A Systematic Review. Circulation. Heart failure. 2020 Sep;13(9):e006881. Epub 2020 Sep 9. PMID: 32900233
  • Patel S, Hoge G, Fellman B, Kaur S, Heung Y, Bruera E, Hui D. Timing of referral to outpatient palliative care for patients with haematologic malignancies. British journal of haematology. 2022 Sep;198(6):974-982. Epub 2022 Jul 21. PMID: 35866185
  • An A, Hui D. Immunotherapy Versus Hospice: Treatment Decision-Making in the Modern Era of Novel Cancer Therapies. Current oncology reports. 2022 Mar;24(3):285-294. Epub 2022 Feb 3. PMID: 35113356
  • Humphrey TJ, Cruickshank JG, Cubitt WD. An outbreak of calicivirus associated gastroenteritis in an elderly persons home. A possible zoonosis? The Journal of hygiene. 1984 Oct;93(2):293-9. PMID: 6094667
  • Hui D, Abdelghani E, Chen J, Dibaj S, Zhukovsky D, Dev R, Tanco K, Haider A, Azhar A, Reddy A, Epner D, Arthur J, Dalal S, Heung Y, Reddy S, De La Cruz M, Liu D, Bruera E. Chronic Non-Malignant Pain in Patients with Cancer Seen at a Timely Outpatient Palliative Care Clinic. Cancers. 2020 Jan 15;12. (1). PMID: 31952220
  • Hui D, Puac V, Shelal Z, Liu D, Maddi R, Kaseb A, Javle M, Overman M, Yennurajalingam S, Gallagher C, Bruera E. Fixed-Dose Netupitant and Palonosetron for Chronic Nausea in Cancer Patients: A Double-Blind, Placebo Run-in Pilot Randomized Clinical Trial. Journal of pain and symptom management. 2021 Aug;62(2):223-232.e1. Epub 2021 Jan 1. PMID: 33388382
  • Hui D, Bruera E. Use of short-acting opioids in the management of breathlessness: an evidence-based review. Current opinion in supportive and palliative care. 2020 Sep;14(3):167-176. PMID: 32701856
  • Mo L, Urbauer DL, Bruera E, Hui D. Recommendations for Palliative and Hospice Care in NCCN Guidelines for Treatment of Cancer. The oncologist. 2021 Jan;26(1):77-83. Epub 2020 Sep 23. PMID: 32915490
  • Hui D, Casarett D. Controversies in Palliative Care: A New JPSM Series. Journal of pain and symptom management. 2023 Jan;65(1):e79. PMID: 36566050
  • Hui D, De La Rosa A, Urbauer DL, Nguyen T, Bruera E. Personalized sedation goal for agitated delirium in patients with cancer: Balancing comfort and communication. Cancer. 2021 Dec 15;127(24):4694-4701. Epub 2021 Aug 25. PMID: 34432293
  • Hui D, Agar M, Maeda I. Should Neuroleptics Be Used in Patients With Delirium Seen by Palliative Care? Journal of pain and symptom management. 2023 Jan;65(1):e81-e85. Epub 2022 Oct 8. PMID: 36220457
  • Hui D, De La Rosa A, Wilson A, Nguyen T, Wu J, Delgado-Guay M, Azhar A, Arthur J, Epner D, Haider A, De La Cruz M, Heung Y, Tanco K, Dalal S, Reddy A, Williams J, Amin S, Armstrong TS, Breitbart W, Bruera E. Neuroleptic strategies for terminal agitation in patients with cancer and delirium at an acute palliative care unit: a single-centre, double-blind, parallel-group, randomised trial. The Lancet. Oncology. 2020 Jul;21(7):989-998. Epub 2020 May 29. PMID: 32479786
  • Chang YK, Allen LA, McClung JA, Denvir MA, Philip J, Mori M, Perez-Cruz P, Cheng SY, Collins A, Hui D. Criteria for Referral of Patients With Advanced Heart Failure for Specialized Palliative Care. Journal of the American College of Cardiology. 2022 Jul 26;80(4):332-344. PMID: 35863850
  • Hui D, De La Rosa A, Bruera E. State of Integration of Palliative Care at National Cancer Institute-Designated and Nondesignated Cancer Centers. JAMA oncology. 2020 Aug 1;6(8):1292-1295. PMID: 32614444
  • Mori M, Morita T, Bruera E, Hui D. Prognostication of the Last Days of Life. Cancer research and treatment. 2022 Jul;54(3):631-643. Epub 2022 Mar 30. PMID: 35381165
  • Hui D, Paiva CE, Del Fabbro EG, Mori M. Prognostication, palliative care, and patient outcomes (reply to Rossi et al.). Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2020 Apr;28(4):1547-1548. Epub 2020 Jan 6. PMID: 31903534
  • Hui D, Nortje N, George M, Wilson K, Urbauer DL, Lenz CA, Wallace SK, Andersen CR, Mendoza T, Haque S, Ahmed S, Delgado-Guay M, Dalal S, Rathi N, Reddy A, McQuade J, Flowers C, Pisters P, Aloia T, Bruera E. Impact of an Interdisciplinary Goals-of-Care Program Among Medical Inpatients at a Comprehensive Cancer Center During the COVID-19 Pandemic: A Propensity Score Analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2023 Jan 20;41(3):579-589. Epub 2022 Oct 6. PMID: 36201711
  • Mo L, Geng Y, Chang YK, Philip J, Collins A, Hui D. Referral criteria to specialist palliative care for patients with dementia: A systematic review. Journal of the American Geriatrics Society. 2021 Jun;69(6):1659-1669. Epub 2021 Mar 2. PMID: 33655535
  • Amano K, Liu D, Bruera E, Hui D. Collapse of Fluid Balance and Association with Survival in Patients with Advanced Cancer Admitted to a Palliative Care Unit: Preliminary Findings. Journal of palliative medicine. 2020 Apr;23(4):459-465. Epub 2019 Oct 29. PMID: 31657649
  • Azhar A, Hui D. Management of Physical Symptoms in Patients with Advanced Cancer during the Last Weeks and Days of Life. Cancer research and treatment. 2022 Jul;54(3):661-670. Epub 2022 Jun 30. PMID: 35790195
  • Zimmermann C, Buss MK, Rabow MW, Hannon B, Hui D. Should Outpatient Palliative Care Clinics in Cancer Centers be Stand Alone or Embedded? Journal of pain and symptom management. 2023 Feb;65(2):e165-e170. Epub 2022 Nov 25. PMID: 36437178
  • Mo L, Hui D. Reply to comment on: Referral criteria to specialist palliative care for patients with dementia-A systematic review. Journal of the American Geriatrics Society. 2021 Jul;69(7):2038-2039. Epub 2021 May 3. PMID: 33939835
  • Goswami R, Moore J, Bruera E, Hui D. Assessment of the Decision-Making Capacity for Clinical Research Participation in Patients With Advanced Cancer in the Last Weeks of Life. Journal of pain and symptom management. 2020 Aug;60(2):400-406. Epub 2020 Feb 24. PMID: 32105788
  • Chang YK, McClung JA, Allen LA, Philip J, Hui D. Reply: Early Integration of Specialist Palliative Care in Advanced Heart Failure: A Multipronged Approach. Journal of the American College of Cardiology. 2022 Nov 29;80(22):e205-e206. PMID: 36423999
  • Simon ST, Mori M, Ekström M, Pralong A, Yamaguchi T, Hui D. Should Benzodiazepines be Used for Reducing Dyspnea in Patients with Advanced Illnesses? Journal of pain and symptom management. 2023 Mar;65(3):e219-e223. Epub 2022 Nov 29. PMID: 36455801
  • Hui D, Darke AK, Guthrie KA, Subbiah IM, Unger JM, Hershman DL, Krouse RS, Bakitas M, O'Rourke MA. Association Between Health-Related Quality of Life and Progression-Free Survival in Patients With Advanced Cancer: A Secondary Analysis of SWOG Clinical Trials. JCO oncology practice. 2022 Apr;18(4):e442-e451. Epub 2021 Oct 4. PMID: 34606328